PhRMA v. Florida
The Pharmaceutical Research & Manufacturers of America's request for a preliminary injunction against Florida Medicaid's preferred drug program will be denied, Tallahassee, Fla. federal court Magistrate Judge William Sherrill says during Sept. 20 hearing. "I don't see that the federal law prohibits a prior authorization program that furthers other state interests...as long as it keeps intact the idea of the [federal Medicaid] formulary," Sherrill said. The program was approved as a Medicaid plan amendment by HHS Sept. 18. Manufacturers are expected to offer supplemental rebates to the state in exchange for having their drugs on the preferred list
You may also be interested in...
GlaxoSmithKline's discounts to the Florida state Medicaid program are not out of line with agreements with other states, CEO J.P. Garnier told the Bear Stearns "virtual" healthcare conference Sept. 24.
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011